US Stock MarketDetailed Quotes
AONCW AMERICAN ONCOLOGY NETWORK INC C/WTS 20/09/2028(TO PUR COM)
- 0.180
- 0.0000.00%
15min DelayClose Jul 12 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.180Open0.180Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.58652wk High0.00P/B0Float Cap0.00152wk Low--Dividend TTM0Shs Float0.586Historical High--Div YieldTTM0.00%Amplitude0.001Historical Low--Avg Price1Lot Size
AMERICAN ONCOLOGY NETWORK INC C/WTS 20/09/2028(TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | 13,819.45%45.14M | -167.07%-18.12M | -42.12%-11.96M | -329K | 74.24%-6.78M | -8.41M | -170.72%-26.34M | 37.25M |
| Net income from continuing operations | -1,579.74%-24.96M | -2,539.17%-63.15M | -1,741.19%-22.35M | ---1.49M | 2,565.71%2.59M | --1.36M | -100.48%-105K | --21.95M |
| Operating gains losses | -1,354.46%-1.27M | 8,508.26%10.17M | --591K | --101K | -12,200.00%-121K | ---- | --1K | ---- |
| Depreciation and amortization | 2.60%4.55M | -2.01%16.74M | 4.45%4.18M | --4.43M | 181.02%17.08M | --4M | 66.27%6.08M | --3.66M |
| Deferred tax | --2.89M | --384K | --309K | --0 | --0 | --0 | 166.72%786K | ---1.18M |
| Other non cash items | 22.16%215K | 25.52%787K | 28.40%217K | --176K | -62.14%627K | --169K | 147.16%1.66M | --670K |
| Change In working capital | 1,609.88%53.62M | 144.78%12.07M | 136.95%5.1M | ---3.55M | 22.47%-26.96M | ---13.81M | -386.78%-34.78M | --12.13M |
| -Change in receivables | 72.31%-3.67M | 104.24%1.19M | 216.82%14.68M | ---13.27M | 28.03%-28M | ---12.56M | 6.51%-38.9M | ---41.61M |
| -Change in inventory | -94.21%281K | -315.51%-8.09M | -138.15%-6.72M | --4.85M | 81.02%-1.95M | ---2.82M | -63.58%-10.26M | ---6.27M |
| -Change in prepaid assets | -119.88%-752K | -364.74%-1.61M | -2,347.06%-832K | ---342K | 132.24%607K | ---34K | -291.48%-1.88M | ---481K |
| -Change in payables and accrued expense | 763.24%67.13M | 77.21%29.51M | -86.02%583K | --7.78M | -43.25%16.65M | --4.17M | -31.94%29.34M | --43.11M |
| -Change in other current assets | -62.03%-4.58M | -51.54%-2.65M | 60.50%-542K | ---2.83M | -71.20%-1.75M | ---1.37M | -85.64%-1.02M | ---550K |
| -Change in other current liabilities | -1,980.00%-4.79M | 28.59%-6.27M | -73.32%-2.06M | --255K | -730.27%-8.79M | ---1.19M | 89.66%1.39M | --735K |
| -Change in other working capital | ---- | ---- | ---- | ---- | 72.17%-3.74M | --0 | -178.23%-13.45M | --17.19M |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | 13,819.45%45.14M | -167.07%-18.12M | -42.12%-11.96M | ---329K | 74.24%-6.78M | ---8.41M | -170.72%-26.34M | --37.25M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | 157.59%1.52M | -153.98%-35.53M | -1,065.34%-10.86M | -2.64M | -30.83%-13.99M | -932K | 27.12%-10.69M | -14.67M |
| Net PPE purchase and sale | -48.79%-4.13M | -126.64%-11.58M | -72.13%-2.06M | ---2.78M | 33.12%-5.11M | ---1.2M | 37.49%-7.64M | ---12.22M |
| Net business purchase and sale | ---- | --0 | ---- | ---- | 99.84%-5K | ---- | -244.59%-3.22M | ---933K |
| Net investment purchase and sale | 29,336.84%5.56M | -151.58%-25.08M | -35,423.08%-9.18M | ---19K | ---9.97M | --26K | --0 | --0 |
| Net other investing changes | -35.29%99K | 2.75%1.12M | 57.02%380K | --153K | 581.25%1.09M | --242K | 110.53%160K | ---1.52M |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | 157.59%1.52M | -153.98%-35.53M | -1,065.34%-10.86M | ---2.64M | -30.83%-13.99M | ---932K | 27.12%-10.69M | ---14.67M |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | -141.90%-254K | 260.10%55.27M | 28.22%-295K | -105K | -42.18%15.35M | -411K | 63.27%26.54M | 16.26M |
| Net issuance payments of debt | -49.52%-157K | -103.75%-593K | -96.19%-206K | ---105K | -42.87%15.82M | ---105K | 329.56%27.7M | ---12.07M |
| Net common stock issuance | ---97K | --55.43M | ---88K | --0 | --0 | --0 | --0 | --28.5M |
| Net other financing activities | ---- | 190.36%431K | 99.67%-1K | ---- | 58.63%-477K | ---306K | -551.41%-1.15M | ---177K |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | -141.90%-254K | 260.10%55.27M | 28.22%-295K | ---105K | -42.18%15.35M | ---411K | 63.27%26.54M | --16.26M |
| Net cash flow | ||||||||
| Beginning cash position | 5.99%28.54M | -16.78%26.93M | 40.81%51.65M | --26.93M | -24.48%32.35M | --36.68M | 967.58%42.84M | --4.01M |
| Current changes in cash | 1,608.12%46.41M | 129.72%1.61M | -136.90%-23.11M | ---3.08M | 48.25%-5.43M | ---9.76M | -127.01%-10.49M | --38.83M |
| End cash Position | 214.24%74.94M | 5.99%28.54M | 5.99%28.54M | --23.85M | -16.78%26.93M | --26.93M | -24.48%32.35M | --42.84M |
| Free cash flow | 1,420.19%41.01M | -117.51%-30.4M | -39.39%-14.71M | ---3.11M | 59.67%-13.98M | ---10.56M | -238.51%-34.66M | --25.02M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg